- Report
- February 2025
- 120 Pages
Global
From €2189EUR$2,490USD£1,886GBP
- Report
- November 2024
- 100 Pages
Global
From €2189EUR$2,490USD£1,886GBP
- Report
- July 2025
- 459 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 177 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- April 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- February 2025
- 200 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- January 2025
- 175 Pages
Global
From €3948EUR$4,490USD£3,402GBP
- Report
- July 2025
- 281 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 277 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 162 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 192 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 246 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- July 2025
- 273 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- April 2025
- 233 Pages
Global
From €2198EUR$2,500USD£1,894GBP
- Report
- January 2025
- 207 Pages
Global
From €2198EUR$2,500USD£1,894GBP
- Report
- July 2024
- 163 Pages
Global
From €2198EUR$2,500USD£1,894GBP
- Report
- July 2025
- 372 Pages
Global
From €5143EUR$5,850USD£4,432GBP
- Report
- January 2025
- 136 Pages
Global
From €2637EUR$2,999USD£2,272GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more